Evidence map›Paper›PMID 20351285›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration.

Anil Rana, Erwin Seinen, Katarzyna Siudeja, Remco Muntendam, Balaji Srinivasan, Johannes J van der Want, Susan Hayflick, Dirk-Jan Reijngoud, Oliver Kayser, Ody C M Sibon

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. PKAN pathogenesis and treatment.Molecular genetics and metabolism · 2022
    Review
  20. Bi-Allelic Mutations in ZebrafishInternational journal of molecular sciences · 2022
    Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anil RanaDepartment of Cell Biology, Radiation and Stress Cell Biology, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
Erwin Seinen
Katarzyna Siudeja
Remco Muntendam
Balaji Srinivasan
Johannes J van der Want
Susan Hayflick
Dirk-Jan Reijngoud
Oliver Kayser
Ody C M Sibon

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pantothenate kinase-associated neurodegeneration (PKAN), a progressive neurodegenerative disorder, is associated with impairment of pantothenate kinase function. Pantothenate kinase is the first enzyme required for de novo synthesis of CoA, an essential metabolic cofactor. The pathophysiology of PKAN is not understood, and there is no cure to halt or reverse the symptoms of this devastating disease. Recently, we and others presented a PKAN Drosophila model, and we demonstrated that impaired function of pantothenate kinase induces a neurodegenerative phenotype and a reduced lifespan. We have explored this Drosophila model further and have demonstrated that impairment of pantothenate kinase is associated with decreased levels of CoA, mitochondrial dysfunction, and increased protein oxidation. Furthermore, we searched for compounds that can rescue pertinent phenotypes of the Drosophila PKAN model and identified pantethine. Pantethine feeding restores CoA levels, improves mitochondrial function, rescues brain degeneration, enhances locomotor abilities, and increases lifespan. We show evidence for the presence of a de novo CoA biosynthesis pathway in which pantethine is used as a precursor compound. Importantly, this pathway is effective in the presence of disrupted pantothenate kinase function. Our data suggest that pantethine may serve as a starting point to develop a possible treatment for PKAN.

Indexed as

Gene Expression RegulationAnimalsBrainCoenzyme ADrosophilaHumansMitochondriaModels, BiologicalMutationOxidative StressOxygenPantetheinePantothenate Kinase-Associated NeurodegenerationPhenotypePhosphotransferases (Alcohol Group Acceptor)Coenzyme AOxygenPantetheinepantethinepantothenate kinasePhosphotransferases (Alcohol Group Acceptor)

Identifiers

PMID20351285
PMCPMC2872433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.